GENE ONLINE|News &
Opinion
Blog

Funding
Funding Series B FundingPrecision Oncology
Pfizer-backed Flare Taps Caris To Boost Precision Oncology Pipeline
2023-04-17
Funding Kidney Disease
In-Home Kidney Disease Management Company, Monogram, Raises $375 Million
2023-01-13
Startups Chemoproteomics
Belharra Therapeutics Exits Stealth With $130 Million And A Genentech Deal
2023-01-05
Funding Immunotherapy
Zenas Picks Up $118 Million To Advance Phase 3 For Autoimmune Candidate
2022-11-10
Funding FDA
Nineteen Grants and Two Contracts Grab $38 Million In Support From the FDA
2022-10-17
Funding Funding
Andera Partners Drums Up $443 Million For Its Largest Life Sciences Fund
2022-10-11
Funding Oncology
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Funding Theravance Biopharma
Theravance Allots $250 Million to Repurchase Shares, Removing GSK as a Shareholder
2022-09-20
Funding Cell and Gene Therapy
Big Pharma-Backed Capstan Launches With $165 Million To Combine Cell Therapy And mRNA Technology
2022-09-15
Funding CDMO
Forge Biologics Raises $90 Million To Expand Gene Therapy CDMO
2022-09-14
Funding Series D Funding
Series D Funding Brings Radiopharmaceutical Company RayzeBio to $418 million in Total
2022-09-13
Funding Mitochondrial DNA
Pretzel Therapeutics Starts Off With $72.5 Million To Modify Mitochondria
2022-09-13
Funding Plaque Psoriasis
Competing With BMS’s New Psoriasis Drug, Nimbus Gathers $125 Million to Advance Development
2022-09-13
Funding Antisense RNA
RNA-Focused Orbital Therapeutics Makes its Industry Debut with Beam Partnership
2022-09-08
Funding Biomanufacturing
NC – Life Sciences Manufacturing Coalition Wins $25 million in Grant Funding
2022-09-02
1 2 3 4 … 11
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top